Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental HyperinflammationImmunology Published on 2020-05-292022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, [키워드] 2019-nCoV Antiviral antiviral immune response Asymptomatic boost caused cellular protease China complications coronavirus COVID-19 COVID-19 progression COVID-19 severity Cytokine release syndrome Date determine develop disease Disease progression drug drugs targeting event Factor help host cell hyperinflammation Hyperinflammatory immune include individual Inflammatory responses inhibit SARS-CoV-2 Intervention key factor lesson Lungs mechanism of action monoclonal antibody multifactorial occur pandemic pro-inflammatory cytokine randomized clinical trials reported Repurposed drug SARS-CoV-2 SARS-CoV-2 replication serine protease inhibitor severe COVID-19 Spread the timing transmission of SARS-CoV-2 Treatment strategies viral infection [DOI] 10.3389/fimmu.2020.01131 PMC 바로가기 [Article Type] Immunology
Impact of Fundamental Diseases on Patients With COVID-19Original Research Published on 2020-05-072022-10-31 Journal: Disaster Medicine and Public Health Preparedness [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome age analysis carried Characteristics China Chinese coronavirus coronavirus disease COVID-19 COVID-19 progression death demonstrated Diseases epidemiological females Gender Health Impact infected with COVID-19 information Local male media median median age men occurred Older older patient outbreak patients positively correlated recorded released reported Retrospective study risk of death SARS-CoV-2 Specific Symptom Symptoms the elderly the SARS-CoV-2 virus Wuhan, China [DOI] 10.1017/dmp.2020.139 PMC 바로가기 [Article Type] Original Research